Bayer Group
Consolidated Statements of Comprehensive Income

 

 

Q2 2016

Q2 2017

 

H1 2016

H1 2017

 

 

€ million

€ million

 

€ million

€ million

1

Total changes recognized outside profit or loss

Income after income taxes

 

1,448

1,477

 

3,029

3,748

of which attributable to noncontrolling interest

 

68

253

 

138

441

of which attributable to Bayer AG stockholders

 

1,380

1,224

 

2,891

3,307

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

(844)

300

 

(3,407)

905

Income taxes

 

235

(132)

 

991

(327)

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

(609)

168

 

(2,416)

578

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

(609)

168

 

(2,416)

578

Changes in fair values of derivatives designated as cash flow hedges

 

(129)

10

 

(76)

(78)

Reclassified to profit or loss

 

(19)

(27)

 

(35)

27

Income taxes

 

49

8

 

49

23

Other comprehensive income from cash flow hedges

 

(99)

(9)

 

(62)

(28)

Changes in fair values of available-for-sale financial assets

 

14

(27)

 

26

(34)

Reclassified to profit or loss

 

 

Income taxes

 

(5)

(1)

 

(9)

8

Other comprehensive income from available-for-sale financial assets

 

9

(28)

 

17

(26)

Changes in exchange differences recognized on translation of operations outside the eurozone

 

301

(1,213)

 

(208)

(1,384)

Reclassified to profit or loss

 

 

Other comprehensive income from exchange differences

 

301

(1,213)

 

(208)

(1,384)

Other comprehensive income relating to associates accounted for using the equity method

 

(6)

40

 

12

47

Other comprehensive income that may be reclassified subsequently to profit or loss

 

205

(1,210)

 

(241)

(1,391)

Total other comprehensive income1

 

(404)

(1,042)

 

(2,657)

(813)

of which attributable to noncontrolling interest

 

(9)

(86)

 

(110)

(63)

of which attributable to Bayer AG stockholders

 

(395)

(956)

 

(2,547)

(750)

Total comprehensive income

 

1,044

435

 

372

2,935

of which attributable to noncontrolling interest

 

59

167

 

28

378

of which attributable to Bayer AG stockholders

 

985

268

 

344

2,557